Literature DB >> 26416283

Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation.

Yun Xiao1, Guilin Qiao2, Juan Tang3, Rong Tang3, Hui Guo4, Samantha Warwar4, Wallace Y Langdon5, Lijian Tao6, Jian Zhang7.   

Abstract

Previously, we demonstrated that CD28 and CTLA-4 signaling control Casitas-B-lineage lymphoma (Cbl)-b protein expression, which is critical for T cell activation and tolerance induction. However, the molecular mechanism(s) of this regulation remains to be elucidated. In this study, we found that Cbl-b fails to undergo tyrosine phosphorylation upon CD3 stimulation because SHP-1 is recruited to and dephosphorylates Cbl-b, whereas CD28 costimulation abrogates this interaction. In support of this finding, T cells lacking SHP-1 display heightened tyrosine phosphorylation and ubiquitination of Cbl-b upon TCR stimulation, which correlates with decreased levels of Cbl-b protein. The aberrant Th2 phenotype observed in T cell-specific Shp1(-/-) mice is reminiscent of heightened Th2 response in Cblb(-/-) mice. Indeed, overexpressing Cbl-b in T cell-specific Shp1(-/-) T cells not only inhibits heightened Th2 differentiation in vitro, but also Th2 responses and allergic airway inflammation in vivo. Therefore, SHP-1 regulates Cbl-b-mediated T cell responses by controlling its tyrosine phosphorylation and ubiquitination.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26416283      PMCID: PMC4610872          DOI: 10.4049/jimmunol.1501200

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

Review 1.  T cell anergy.

Authors:  Ronald H Schwartz
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 2.  CD28-mediated co-stimulation: a quantitative support for TCR signalling.

Authors:  Oreste Acuto; Frédérique Michel
Journal:  Nat Rev Immunol       Date:  2003-12       Impact factor: 53.106

3.  WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation.

Authors:  Alessandra Magnifico; Seth Ettenberg; Cuihong Yang; Jennifer Mariano; Swati Tiwari; Shengyun Fang; Stan Lipkowitz; Allan M Weissman
Journal:  J Biol Chem       Date:  2003-08-07       Impact factor: 5.157

4.  Ubiquitin ligases in T cell activation and autoimmunity.

Authors:  Jian Zhang
Journal:  Clin Immunol       Date:  2004-06       Impact factor: 3.969

5.  Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.

Authors:  Myung-Shin Jeon; Alex Atfield; K Venuprasad; Connie Krawczyk; Renu Sarao; Chris Elly; Chun Yang; Sudha Arya; Kurt Bachmaier; Leon Su; Dennis Bouchard; Russel Jones; Mathew Gronski; Pamela Ohashi; Teiji Wada; Debra Bloom; C Garrison Fathman; Yun-Cai Liu; Josef M Penninger
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

6.  Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins.

Authors:  Vigo Heissmeyer; Fernando Macián; Sin-Hyeog Im; Rajat Varma; Stefan Feske; K Venuprasad; Hua Gu; Yun-Cai Liu; Michael L Dustin; Anjana Rao
Journal:  Nat Immunol       Date:  2004-02-15       Impact factor: 25.606

7.  Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling.

Authors:  D R Plas; R Johnson; J T Pingel; R J Matthews; M Dalton; G Roy; A C Chan; M L Thomas
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

8.  Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex.

Authors:  S A Ettenberg; A Magnifico; M Cuello; M M Nau; Y R Rubinstein; Y Yarden; A M Weissman; S Lipkowitz
Journal:  J Biol Chem       Date:  2001-05-24       Impact factor: 5.157

9.  Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b.

Authors:  Gareth C Davies; Seth A Ettenberg; Ashley O Coats; Mark Mussante; Sarangan Ravichandran; Jack Collins; Marion M Nau; Stan Lipkowitz
Journal:  Oncogene       Date:  2004-09-16       Impact factor: 9.867

10.  RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3.

Authors:  John R Lukens; Peter Vogel; Gordon R Johnson; Michelle A Kelliher; Yoichiro Iwakura; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Nature       Date:  2013-05-26       Impact factor: 49.962

View more
  20 in total

1.  TAM receptors attenuate murine NK-cell responses via E3 ubiquitin ligase Cbl-b.

Authors:  Leilani M Chirino; Suresh Kumar; Mariko Okumura; David E Sterner; Michael Mattern; Tauseef R Butt; Taku Kambayashi
Journal:  Eur J Immunol       Date:  2019-09-30       Impact factor: 5.532

2.  Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells.

Authors:  Giuliana P Mognol; Roberto Spreafico; Victor Wong; James P Scott-Browne; Susan Togher; Alexander Hoffmann; Patrick G Hogan; Anjana Rao; Sara Trifari
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-10       Impact factor: 11.205

3.  Akt-1 and Akt-2 Differentially Regulate the Development of Experimental Autoimmune Encephalomyelitis by Controlling Proliferation of Thymus-Derived Regulatory T Cells.

Authors:  Song Ouyang; Qiuming Zeng; Na Tang; Hui Guo; Rong Tang; Weifan Yin; Aimin Wang; Hongyu Tang; Jiru Zhou; Hong Xie; Wallace Y Langdon; Huan Yang; Jian Zhang
Journal:  J Immunol       Date:  2019-01-28       Impact factor: 5.422

4.  T Cells Deficient in the Tyrosine Phosphatase SHP-1 Resist Suppression by Regulatory T Cells.

Authors:  Emily R Mercadante; Ulrike M Lorenz
Journal:  J Immunol       Date:  2017-05-26       Impact factor: 5.422

Review 5.  Application of ATAC-seq in tumor-specific T cell exhaustion.

Authors:  Chufeng Chen; Jiaying Liu; Yidong Chen; Anqi Lin; Weiming Mou; Lingxuan Zhu; Tao Yang; Quan Cheng; Jian Zhang; Peng Luo
Journal:  Cancer Gene Ther       Date:  2022-07-06       Impact factor: 5.987

Review 6.  Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

Authors:  Elia Moreno-Cubero; Juan-Ramón Larrubia
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

Review 7.  Regulation of immune responses by E3 ubiquitin ligase Cbl-b.

Authors:  Rong Tang; Wallace Y Langdon; Jian Zhang
Journal:  Cell Immunol       Date:  2018-11-07       Impact factor: 4.868

8.  Quantitative Interactomics of Lck-TurboID in Living Human T Cells Unveils T Cell Receptor Stimulation-Induced Proximal Lck Interactors.

Authors:  Xien Yu Chua; Timothy Aballo; William Elnemer; Melanie Tran; Arthur Salomon
Journal:  J Proteome Res       Date:  2020-11-13       Impact factor: 4.466

Review 9.  E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.

Authors:  D Jafari; M J Mousavi; S Keshavarz Shahbaz; L Jafarzadeh; S Tahmasebi; J Spoor; A Esmaeilzadeh
Journal:  Clin Exp Immunol       Date:  2021-01-10       Impact factor: 5.732

10.  Cbl-b Deficiency Mediates Resistance to Programmed Death-Ligand 1/Programmed Death-1 Regulation.

Authors:  Mai Fujiwara; Emily J Anstadt; Robert B Clark
Journal:  Front Immunol       Date:  2017-01-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.